Oncologic Nursing Part 2 Blaq

Embed Size (px)

Citation preview

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    1/106

    Importance of CancerDetection and Testing

    Detecting cancers early is an importantstep in preventing significant healthproblems.

    Give the accurate manage for thepresent illness(stage) of patient

    To prevent further complication

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    2/106

    Outcomes in

    Detecting Cancer True positive- test indicates that a patient has a disease

    that the patient does indeed have

    False positive

    - if the test indicates that a patient has adisease when she does not

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    3/106

    Outcomes in

    Detecting Cancer True negative - test indicates the patient is disease-

    free, and this is indeed the case

    False negative

    - test indicates the patient is healthywhen in fact the patient has the disease

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    4/106

    Specificity of Medical

    Tests Sensitivity refers to how accurately a testidentifies people who have the disease.

    Specificity refers to how accurately a testidentifies people who do not have the disease

    The best medical tests have high sensitivity andhigh specificity.

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    5/106

    SENSITIVITY It refers to the proportion of the times that a

    test yields true positives.

    The closer the sensitivity is to 100%, the morelikely a positive result actually means that thepatient has a disease.

    The sensitivity of a medical test is a measure of

    how well the test identifies people who have aparticular disease.

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    6/106

    SPECIFICITY It refers to the proportion of the time that

    a test yields true negatives.

    The closer the specificity is to 100%, themore likely a negative result means that thepatient is truly disease-free.

    The specificity of a medical test is ameasure of how well the test identifiespeople who do not have a particular disease

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    7/106

    Importance:

    samples may show cancer cells,

    proteins or other substances madeby the cancer

    idea of how well your organs arefunctioning and if they've beenaffected by cancer

    enera

    Detection

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    8/106

    Non - Invasive InvasiveTechniques

    Analysis of Biopsy

    Complete Blood

    Count (CBC)UltrasoundMRIPET ScanCT Scan

    Fine Needle

    Aspiration

    Core Needle Biopsy

    Immunohistochemistry

    (IHC)

    Fluorescent In SituHybridization (FISH)

    enera

    Detection

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    9/106

    A. Complete blood count (CBC)It provides information about the number, parts,

    shape, and structure of the different cell types

    found in blood.3 Main Types of Blood cells: WBC RBC Platelets

    Blood cancers may be detected using this test iftoo many or too few of a type of blood cell or

    abnormal cells are found. eg., Leukemias

    and Diagnostic

    Techniques

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    10/106

    Leukocyte ( WBC)

    Are major players in the immune system and help

    defend against infection and disease. WBC can be divided into two main groups:

    Phagocytes

    Lymphocytes

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    11/106

    Leukocyte ( WBC)

    Phagocytes- Are cells that are able to consume and break

    down foreign material, invading microbes andbroken down cells/cell parts.

    They get their name from the Greek 'phagein',

    to eat.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    12/106

    Leukocyte ( WBC) Lymphocytes-

    These are recognition cells responsible for

    initiating the specific immune response of theimmune system.

    Three Major Types of Lymphocytes

    B cells T cells

    natural killer cells (NK cells)

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    13/106

    T- Cells Formed by the pluripotent stem cells in

    the bone marrow, T-cells mature in thethymus (a small organ located in the upperportion of the chest).

    Two Subtypes of T cells; cytotoxic T cells (CD8 cells) helper T cells (CD4 cells).

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    14/106

    T- Cells Cytotoxic T cells (CD8 cells) bind specifically to targetcells; virally infected cells,

    cancer cells, or any foreign cells. After binding,cytotoxic T cells directly destroy the target cell.

    Helper T cells (CD4 cells)release special chemicals that help activate other cells

    of the immune response, including; B cells, cytotoxic Tcells, other helper T cells, NK cells, and macrophages.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    15/106

    B- CellsThese cells are produced from

    the pluripotent stem cells in

    the bone marrow and stay inthe marrow to mature.

    B cells bind to their specificantigens, become activated

    'plasma' cells and secretelarge amounts antibodies.

    Natural killercells (NK cells)

    It bind to virallyinfected cells andcancer cells anddirectly kill them.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    16/106

    Granulocytesgranules contain

    chemicals and proteins

    (from cells)

    controlinflammatory andimmune functions.

    Granulocytes are alsocapable of engulfingand destroying foreignmatter

    NeutrophilsAre usually the first

    cells to arrive at the

    scene of infection orinflammation

    They engulf anddestroy foreignmatter and then die,forming pus

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    17/106

    Eosinophils

    known to play a

    role in parasiticinfections andallergic

    reactions

    Basophils

    These cells are

    stimulated byother immune cellsand play a role in

    systemic allergicreactions.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    18/106

    Granulocytes

    lack the granulesof granulocytes

    capable ofengulfing and

    destroying foreignmatter.

    Monocytes/Macrophages

    These cells are the largesttype of white blood cell.

    The second cells on the sceneof a problem.

    They engulf and processforeign matter so thatlymphocytes can recognize itand mount a specific defense.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    19/106

    CBC: Red Blood Cells (RBC)

    Red blood cells (also

    called erythrocytes) pick up oxygen inthe lungs and deliver it to the rest ofthe cells in the body.

    2 Subtypes of RBC Hemoglobin

    Hematocrit

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    20/106

    NON-INVASIVEA. Complete blood count (CBC)

    Hemoglobin

    Each red blood cell carries around 300

    million molecules of a protein calledhemoglobin.

    Hemoglobin is what actually grabs andcarries oxygen.

    Each molecule of hemoglobin can carry 4molecules of oxygen

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    21/106

    Hematocrit

    The hematocrit is the proportion of red blood cellsto an entire sample of blood (red blood cells / blood).

    It may also be called packed cell volume (PCV) and itis normally represented as a percentage.

    For example: a hematocrit of 30% means there are

    30 milliliters of red blood cells in 100 milliliters ofblood.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    22/106

    Reticulocyte Count

    Is the percentage of immature red blood

    cells (reticulocytes) in the total red bloodcell count (reticulocytes / red blood cells).

    1-2% of the total RBC count

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    23/106

    Red Blood Cell Indices

    The RBC indices evaluate the structure ofred blood cells and hemoglobin.

    They include: mean corpuscular volume (MCV)

    mean corpuscular hemoglobin (MCH)

    mean corpuscle hemoglobin concentration(MCHC).

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    24/106

    MCV describes the sizeor volume of RBC's

    Classificatioon;

    microcytic (small), normocytic (normal)

    macrocytic (large)

    MCH describes the

    average weight of thehemoglobin in the RBC's.A small RBC will have asmaller MCH.

    MCHC describes theaverage concentration ofhemoglobin in the RBC's

    Classification: hypochromic (lowconcentration, pale color),

    normochromic (normalconcentration, normal color)

    hyperchromic (increasedconcentration, bright redcolor).

    NON-INVASIVERed Blood Cell Indices

    l i d

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    25/106

    Urine cytology- reveal cancer cellsthat could come from the bladder,ureters or kidneys

    Blood protein testing- examine variousproteins in your blood (electrophoresis)can aid in detecting certain abnormal

    immune system proteins

    General Detection and

    Laboratory Techniques

    G l i d

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    26/106

    Tumor marker tests- chemicals madeby tumor cells that can be detected in yourblood

    prostate-specific antigen (PSA)- for prostatecancercancer antigen 125 (CA 125)- for ovarian

    cancer

    Calcitonin- for medullary thyroid canceralpha-fetoprotein (AFP)- for liver cancerhuman chorionic gonadotropin (HCG)- for germ

    cell tumors, such as testicular cancer and

    ovarian cancer

    General Detection and

    Laboratory Techniques

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    27/106

    ULTRASOUND (UTZ)

    is an ultrasound-based diagnostic imagingtechnique used to visualize subcutaneous bodystructures

    A computer program is used to analyze theechoes of sound waves sent into the bodyand generates an image on screen.

    http://en.wikipedia.org/wiki/Ultrasoundhttp://en.wikipedia.org/wiki/Medical_imaginghttp://en.wikipedia.org/wiki/Medical_imaginghttp://en.wikipedia.org/wiki/Ultrasound
  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    28/106

    Purpose of UTZ

    Are good exams to gain important

    information about a suspicious mass

    It can be used to help guide a needle

    during a biopsy.

    ULTRASOUND (UTZ)

    ULTRASOUND (UTZ)

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    29/106

    Can detect lesions in women with dense breasts

    when mammograms cannot.

    Less expensive than a mammogram.

    Present the difference between a cyst and a solidmass without using a needle to draw out fluid (non-

    invasive).

    Never exposed to radiation detect blood flow through vessels

    no known harmful effects to humans.

    ULTRASOUND (UTZ)ADVANTAGES

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    30/106

    ULTRASOUND (UTZ)DISADVANTAGES

    Sometimes it is unable to determine whetheror not a mass is malignant, and a biopsy will berecommended.

    Many cancers cannot be detected via anultrasound.

    Calcifications that are visible on mammograms

    are not visible on ultrasound scans

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    31/106

    MAGNETIC RESONANCEIMAGING(MRI)

    Also called as nuclear magnetic resonanceimaging (NMRI)

    Can locate and describe the gross extentof a mass or tumor but cannotdifferentiate between benign and

    malignant

    http://en.wikipedia.org/wiki/2D-FT_NMRI_and_Spectroscopyhttp://en.wikipedia.org/wiki/2D-FT_NMRI_and_Spectroscopy
  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    32/106

    When contrast agent is not used an MRIcan show: When contrast agent is used MRI canshow:

    contrast agent is not used an MRI can

    show:The shape, size, appearance, and locationof organs, bones, and jointsThe presence of abnormal growthsSigns of inflammation or infection

    size and location of benign or malignant

    growthsenlarged lymph nodeschanges in blood flowextracellular volume

    MAGNETIC RESONANCEIMAGING(MRI)

    P it E i i

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    33/106

    Positron Emission

    Tomography (PET) Is an imaging technique that uses radioactivemolecules to create a dynamic image of internaltissues and organs.

    It produce images that reveal the activity ofliving tissue.

    PET scans use radioactively labeled tracers

    (radiotracers) that are injected into thebloodstream

    PET SCAN

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    34/106

    Drink plenty of water, but do not eat or drink anything(except water) for 6 hours before your exam

    Take your medications normally and drink them with

    ample water Make sure you arrive at the imaging center on time, the

    compound used for the scan breaks down rapidly and ifyou are late, the images may not be as good

    Wear loose fitting clothing

    Do not wear any jewelry; watches, chains, rings,piercings, etc

    PET SCANPreparation

    :

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    35/106

    Tomography

    CTs Scan uses special

    x-rayequipment toobtain cross-

    sectionalpictures of thebody

    http://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=x-ray&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=x-ray&version=Patient&language=English
  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    36/106

    Use In Cancer to:To detect or confirm the presence of a tumor;To provide information about the size and

    location of the tumor and whether it has spread;To guide a biopsy (the removal of cells or tissues

    for examination under a microscope);

    To help plan radiation therapy or surgery; andTo determine whether the cancer is responding

    to treatment.

    Tomography

    CTs Scan

    i

    http://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=biopsy&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=cell&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=radiation%20therapy&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=surgery&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=surgery&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=radiation%20therapy&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=cell&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=biopsy&version=Patient&language=English
  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    37/106

    Biopsy

    - is the removal oftissue from a

    living subject todetermine thepresence orextent of a

    disease- Visualization of

    change cell

    microscopically

    CYTOLOGY SPECIMENSpecimen can be obtain

    from tumors that tend to

    shed cells from their

    surface

    BIOPSY

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    38/106

    BIOPSY

    NEEDLE BIOPSY Incision Biopsy

    Only part of tumoris removedCell tissue only

    NEEDLE BIOPSY Excision BiopsyEntire tumor is

    surgically removed forexaminationUsed for small tumors

    (2-3cm)

    Serve as treatment iftissue margin containno tumor cells

    Bi

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    39/106

    BiopsyInvasive Techniques

    Fine needleaspiration (FNA)uses a small

    needle to collectsmall samples of alesion.

    Core needlebiopsy (CNAB)uses a larger

    needle to collectsamples of a lesion

    Biopsy

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    40/106

    Fine needle aspiration(FNA)

    ADVANTAGES:

    diagnose benign lesions

    Inexpensive, quick, readilyavailable, and very safe

    DISADVANTAGES:

    No ability to differentiate

    between in situ andinvasive breast cance

    Core needle biopsy (CNAB) ADVANTAGES:

    Strong ability to specificallydiagnose benign lesions.

    Some ability to differentiatebetween in situand invasivebreast cancer.

    DISADVANTAGES:

    More invasive, timeconsuming, expensive

    BiopsyInvasive Techniques

    Anal sis of Biops

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    41/106

    Analysis of BiopsySamples

    mmunohistochemistry (IHC)measures protein expression

    using specially labeledantibodies.

    example: Three proteins ofparticular interest in breastcancer are HER2, theestrogen receptor (ER) andthe progesterone receptor(PR).

    Fluorescence in SituHybridization (FISH)

    measures genetic changes (i.e.amplification) using

    fluorescently labeled DNAprobes.

    Is a technique that measuresgene amplification andchromosomal abnormalities usingfluorescently labeled DNAprobes.

    C S ifi

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    42/106

    Cancer SpecificTechniques

    Mammography

    uses low dose

    x-ray to createan image of abreast.

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    43/106

    Techniques

    Direct Visualization Direct VisualizationSigmoidoscopy uses a small tube containing viewing

    equipment to view the colon.

    Virtual Colonoscopy uses an MRI or CT scan tocreate an image of the inside of the colon.Bronchoscopy Endoscopy

    Cystoscopy

    Exploratory Surgery

    C S ifi

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    44/106

    Cancer SpecificTechniques

    Pap smears use a sample of cells from thecervix to detect cervical cancer. Papsmears may also detect ovarian and

    uterine cancers that have migrated to thecervix.

    Prostate specific antigen (PSA) test

    measures levels of a glycoprotein in theblood. Elevated levels of PSA areassociated with prostate cancer

    S ti l L h N d

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    45/106

    Sentinel Lymph NodeBiopsy (SLN)

    Use to detect metastasis

    the hypothetical first lymph node or

    group of nodes reached bymetastasizing cancer cells from a tumor

    used in the staging of certain types of

    cancer to see if they have spread to anylymph node

    Grading and Staging

    http://en.wikipedia.org/wiki/Lymph_nodehttp://en.wikipedia.org/wiki/Lymph_node
  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    46/106

    Grading and StagingGRADING

    Evaluation of degree ofdifferentiation of cancercells

    Grade 1- the least

    malignantTo

    Grade 4- the mostmalignant

    Grade 1- the most

    differentiatedTo

    Grade 4- the leastdifferentiated

    STAGING

    The process of describing thelocal extent of the disease orthe spread of cancer fromthe original site

    Essential in determining thechoice of therapy andassessing prognosis

    Based on information aboutthe tumor size and location inthe body, and whether or notit has spread to other areasof the body

    TNM Staging

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    47/106

    TNM StagingSystem

    Measure tumors in threeways:

    Primary Tumor (T)

    Node (N)

    Metastasize (M) TNM Stag ng

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    48/106

    TNM Stag ngSystem

    Tumor

    T0- no evidence of primary tumor TIS- carcinoma in situ

    T1-T4- ascending degrees of tumor size andinvolvement

    ag ng

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    49/106

    Nodes

    N0- no evidence of disease in lymph nodes

    N1a, N2b- disease found in regional lymphnodes, metastasis not suspected

    N1a, N2b, N3 - disease found in regionallymph nodes, metastasis suspected

    ag ngSystem

    TNM Staging

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    50/106

    Metastasis

    M0- no evidence of distant metastasis M1, M2, M3- Ascending degrees of

    metastasis involvement,including distant nodes

    TNM StagingSystem

    ag ng

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    51/106

    Once the T, N, and M are determined, a Stageof I, II, III, or IV is assigned

    Stage I - (T1,N0,M0) - Early StageStage II - (T2,N1,M0) - Local SpreadStage III - ( T3,N2,M0) Extensive

    spread but no metastasis

    Stage IV (T4,N3,M+) Advancedstage, with distantmetastasis

    ag ngSystem

    Levels of Cancer

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    52/106

    Levels of CancerPrevention and Control

    1.Primary Prevention Focuses on eliminating the

    conditions that cause cancer todevelop Pre-cancerous stage

    Levels of Cancer

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    53/106

    2. Secondary Prevention Refers to early detection

    coupled with effective therapy Cancer maybe curable in early

    stage.

    Levels of CancerPrevention and Control

    Levels of Cancer

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    54/106

    3. Tertiary Prevention Refers to the prevention of

    cancer recurrence, symptomsand complication Involves Supportive Care,

    Rehabilitation and pain relief

    Levels of CancerPrevention and Control

    Pr nc p es o

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    55/106

    Pr nc p es oCancer Treatment

    Objectives:

    Aims to prevent cancer fromspreading locally or recurring/relapsing at sites distant from the

    original location.

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    56/106

    Treatments Surgery Radiation Therapy

    Hormonal Therapy

    Targeted Therapy Antibodies

    Cancer Vaccines

    Complimentary and Alternative Medicines

    Chemotherapy

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    57/106

    TREATMENT MODALITIES

    A. Loco-Regional Treatment

    1. Surgery

    2. Radiation Therapy3. Transplant

    B. Systemic Treatment

    1. Cytotoxic Chemotherapy2. Hormonal Therapy

    SURGERY

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    58/106

    SURGERY The first line of treatment for many solid

    tumors. M single cancer cell is invisible to the naked eye

    but can regrow into a new tumor, a processcalled recurrence

    A local treatment used to remove visible tumorsor the entire organ

    Purposes:DiagnoseCureControlPallative

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    59/106

    SURGERY Local Excision- simple surgery with

    small margin of normal tissuesurrounding tumor.

    En bloc Dissection- removal of tumor,tissues, and any contiguous structures.

    Surgery on Cancer in

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    60/106

    Surgery on Cancer inSitu

    Electrosurgery- application of electricalcurrent to cancerous cells

    Cryosurgery- deep freezing with liquidnitrogen

    Chemosurgery- applied chemotherapeutic

    agents layer by layer with surgical incision. Co2 laser- use of laser for laser excision.

    RADIATION THERAPY

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    61/106

    RADIATION THERAPY

    The use of high-energy ionizing rays totreat a variety of cancers

    Destroys the cells ability to reproduce by

    damaging the cells DNA Rapidly dividing cells are more vulnerable

    to radiation than slower dividing cells

    It can be used alone or in conjunction withother treatments (e.g. chemotherapy andsurgery) to cure or stabilize cancer.

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    62/106

    Objectives: This treatment seeks to relieve symptoms of the

    cancer and to prolong survival, making life more

    comfortable. Types of Radiation Therapy

    External Radiation Therapy

    Internal Radiation Therapy

    Photon Radiation

    RADIATION THERAPY

    Types of Radiation

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    63/106

    Types of RadiationTherapy

    1. External RadiationTherapy Administered by

    high energy X-ray machines(e.g. Betatronand Linear

    Accelerator) ormachinescontainingradiosotope

    External Radiation:

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    64/106

    External Radiation:Nursing Care

    Marks must not remove

    Keep the skin dry

    Talcum and Lotions are contraindicated

    Avoid strong sunlight, extremes temperature,constricting clothes.

    No Eating (NPO)

    Patient is not the SOURCE of Radiation afterthe procedure.

    Types of Radiation

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    65/106

    Internal Radiation Therapy

    Involves the placement of specially

    prepared radioisotopes directlyinto near the tumor itself or intothe systemic circulation

    Also called brachytherapy

    Types of RadiationTherapy

    Types of Internal

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    66/106

    Types of InternalRadiation Therapy

    Sealed Source RT(Brachytherapy)Un Sealed- Source RT

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    67/106

    Sealed- Source RT

    Sealed radiation source isplaced in a cavity or adjacent to

    cancer.

    Ex: Radium, Iridium, Cesium

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    68/106

    INTRACAVITARY Therapy Radioisotope is placed into an applicator, then

    placed into the body cavity for a carefullycalculated time (usually 24 72 H)

    Ex: Radioisotopes: Celsium 137

    Radium 226

    Sealed- Source RT

    l d

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    69/106

    INTERSTITIAL THERAPY

    Radioisotope of choice is placed intoneedles, beads, seeds, ribbons or catheters

    and then implanted directly into the tumor. Implants may be left in the tumor

    temporarily or permanently.

    Ex: Iridium 192, Iodine 125, Celsium 137,Gold 198, Radon 222

    Sealed- Source RT

    UNSEALED SOURCE RT

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    70/106

    UNSEALED SOURCE RT

    Used in Systemic therapy. Source of Radiation is given orally,

    intravenously. PO Administration: Low dose: Graves

    Disease 131I High Dose: Thyroid Ca

    IV Administration: 32p TreatsPolycythemia Vera

    Other Types of

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    71/106

    It uses high energy rayscomposed of particles of energy

    called photons.

    Gamma rays: are produced by

    the breakdown of radioactive

    isotopes of elements such as

    Cobalt-60 and radium

    X-rays: originate from machinesthat excite electrons using

    cathode ray tubes or linear

    accelerators.

    Other Types ofRadiation Therapy

    Nursing Care Highlight

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    72/106

    g g g

    Care of the Client with Sealed Implants of

    Radioactive Sources

    Assign the client to a privateroom, with private bath.

    Place Caution: RadioactiveMaterial sign on the door of

    the clients room. Pregnant nurses should not

    care for these clients; do notallow children younger than 16

    and pregnant women to visit.

    Limit each visitor to hour per day

    Never touch the

    radioactive materialwith bare hands

    Save all dressingsand bed linens until

    after theradioactive sourceis removed.

    RADIATION SAFETY

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    73/106

    RADIATION SAFETY

    Three factors which determine thetotal exposure one receives in a givenradiation field are:

    1. Time of exposure.

    2. Distance from Source.

    3. Amount of shielding present.

    TIME

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    74/106

    TIME

    The less time

    you spend near asource, the lessradiation you will

    receive

    The Shortest Possible Time

    DISTANCE

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    75/106

    DISTANCE As far as possible

    ( can spend moretime at a distanceof 20 feet)

    The farther you getfrom a source, theless radiation youwill receive.

    SHIELDS

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    76/106

    SHIELDS

    The more

    shielding youhave, the lessradiation you will

    receive.

    Protective Lead Apron

    Advantages of

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    77/106

    Advantages ofRadiotherapy

    Destroys quickly dividing cells at the marginsof tumors. Surgery may miss these cellsleading to recurrence of disease.

    Can successfully eradicate growth withoutpermanently damaging the adjacent normal

    In conjunction with other treatments, maycure tumors that are not responsive to anysingle agent.

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    78/106

    II. SYSTEMIC TREATMENT

    HORMONAL THERAPY

    Fights cancer byaltering the

    amounts ofhormones in thebody.

    BIOLOGIC TREATMENTS

    Referred to by many termsincluding: Immunologictherapy, Immunotherapy,

    biotherapy. (Interferon,Interleukin)

    Often used to help restorethe functioning of the

    immune system. Stimulates the disease-

    fighting ability of the body.

    CHEMOTHERAPY

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    79/106

    CHEMOTHERAPY Chemo, refers to a wide

    range of drugs used totreat cancer

    work by damaging the

    dividing cancer cells andpreventing their furtherreproduction

    Death of the normal cells

    produces some of thecommon side-effects ofchemotherapy.

    PRINCIPLE OFCHEMOTHERAPY

    Timing of dose around thecell cycle and in relation to

    other drugs is criticalCombination therapy is

    more effective

    Effectiveness of the drug

    relies on the number ofcells in division

    CHEMOTHERAPY

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    80/106

    The use of powerful drugs to:

    Kill Cancer CellsControl their Growth

    Relieve Pain Symptoms

    CHEMOTHERAPY

    Types of

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    81/106

    Types ofChemotherapy

    1. Primary ChemotherapyThe use chemotherapy alone for the cure ofa specific tumor.

    2. Adjuvant ChemotherapyThe use of chemotherapy after primary,loco regional treatment, with the intent of

    decreasing the relapse rate and improvingsurvival.

    Types of

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    82/106

    Types ofChemotherapy

    3. Neo- adjuvant ChemotherapyThe use of chemotherapy before loco- regionaltreatment with the intent of decreasing tumor

    size enhancing chances for resectability andpreservation of normal structures.

    4. Concurrent Chemotherapy

    The use of chemotherapy combined withradiotherapy in order to increase local responseand control systemic spread.

    ypes o

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    83/106

    ypes oChemotherapy

    5. Palliative Chemotherapy

    The use of chemotherapy in advancedmalignancies, the intent of which is notcure but control of the disease andtumor related symptoms.

    CHEMOTHERAPY

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    84/106

    TypesAntineoplastic Agents- drugs that inhibit and combat the

    development of neoplasms

    Classes:

    AntimetabolitesGenotoxic Drugs

    Alkylating agents:

    Intercalating agents

    Enzyme inhibitors

    CHEMOTHERAPYDRUGS

    CHEMOTHERAPY

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    85/106

    Types

    Spindle Inhibitors

    Additional Chemotherapy Agents

    CHEMOTHERAPY

    ANTIMETABOLITES

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    86/106

    ANTIMETABOLITES

    Drugs that interfere with the formation ofkey biomolecules within the cell.

    work by blocking the activity of enzymes

    These drugs often prevent the normalreplication of DNA , nucleic acids andtherefore cell division.

    Other antimetabolites may interfere withthe creation of RNA or other cellularprocesses

    ANTIMETABOLITES

    http://www.cancerquest.org/dictionary.cfm?lookup_id=DNA&lang=englishhttp://www.cancerquest.org/dictionary.cfm?lookup_id=RNA&lang=englishhttp://www.cancerquest.org/dictionary.cfm?lookup_id=RNA&lang=englishhttp://www.cancerquest.org/dictionary.cfm?lookup_id=DNA&lang=english
  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    87/106

    Classes:Folate Antagonists- known as antifolates

    inhibit dihydrofolate reductase (DHFR), an enzyme

    involved in the formation of nucleotides. When thisenzyme is blocked, nucleotides are not formed,disrupting DNA replication and cell division

    Ex. Methotrexate (Wellcovorin):

    ADVERSE EFFECT Bone marrow depression

    stomatitis

    ANTIMETABOLITES

    ANTIMETABOLITES

    http://www.cancerquest.org/index.cfm?page=430http://www.cancerquest.org/index.cfm?page=430
  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    88/106

    Purine Antagonists purines (adenine and guanine) are chemicals used to

    build the nucleotides of DNA and RNA

    inhibiting DNA synthesis in two different ways They can inhibit the production of the purine

    containing nucleotides, adenine and guanine

    They may be incorporated into the DNA moleculeduring DNA synthesis

    Ex. 6-Mercaptopurine, Dacarbazine, Fludarabine

    ANTIMETABOLITES

    ANTIMETABOLITES

    http://www.cancerquest.org/index.cfm?page=435http://www.cancerquest.org/index.cfm?page=435
  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    89/106

    Pyrimidine Antagonists act to block the synthesis of pyrimidine containing

    nucleotides (C and T in DNA; C and U in RNA). The drugs used to block the construction of these

    nucleotide have structures that are similar to the naturalcompound.

    By acting as 'decoys', these drugs can prevent theproduction of the finished nucleotides. They may exerttheir effects at different steps in that pathway and maydirectly inhibit crucial enzymes.

    Ex. 5-fluorouracil; Arabinosylcytosine

    ANTIMETABOLITES

    eno ox c

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    90/106

    Drugs that damage DNA. By causingDNA damage, these agents interferewith DNA replication, and cell division

    3 Treatments: Alkylating Agents

    Intercalating Agents

    Enzyme Inhibitors

    eno ox c

    Drugs

    eno ox c

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    91/106

    Alkylating agents:

    The first class of chemotherapy agentsused. These drugs modify the bases ofDNA, interfering with DNA replication

    and transcription and leading to mutations

    eno ox c

    Drugs

    eno ox c

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    92/106

    Intercalating agents These drugs wedge themselves into the spaces

    between the nucleotides in the DNA double helix.They interfere with transcription, replication and

    induce mutations.

    Enzyme inhibitors

    These drugs inhibit key enzymes, such as

    topoisomerases, involved in DNA replicationinducing DNA damage.

    eno ox c

    Drugs

    Spindle Inhibitors

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    93/106

    Spindle Inhibitors

    These agents prevent proper cell division byinterfering with the cytoskeletalcomponents that enable one cell to divide

    into two. Vinca Alkaloids

    Paclitaxel (Taxol)

    Docetaxel (Taxotere)Ixabepilone (Ixempra)

    Chemotherapy

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    94/106

    Chemotherapy

    Agents While many of the commonly used chemotherapyagents fit into one of the three previously describedgroupings (Genotoxic, Cytoskeletal, and Anti-metabolite), some of them work through mechanisms

    that do not neatly fit into one of these categories. Arsenic trioxide (Trisenox)

    Bleomycin

    Hydroxyurea Streptozocin

    Chemotherapeutic

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    95/106

    pAdministration

    Oral

    IM/ SQ

    IV

    Central Venous Catheter

    Venous Access Devices (VAD)

    Intraarterial Route

    Intraperitoneal Route

    STEM CELLS

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    96/106

    STEM CELLS Stem cells are able to grow

    into other blood cells that

    mature and function as

    needed in the body.

    Stem cells create the threemain types of blood cells:

    red blood cells

    white blood cells

    platelets

    Stem cells

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    97/106

    Stem cells

    Location Bone marrow (the spongy center of thebone where blood cells are made) Peripheral blood (found in blood vessels

    throughout the body) Cord blood (found in the umbilical cord and

    collected after a babys birth)

    Stem cells for transplantation are obtained from any of these threeplaces.

    Transplant in Cancer

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    98/106

    Transplant in Cancer

    A. Stem Cell Transplant a procedure that is used

    in conjunction with high-

    dose chemotherapy more effective thanconventionalchemotherapy indestroying myeloma cells

    restore blood cellproduction

    Types of Stem Cell

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    99/106

    ypTransplants

    Bone marrow transplantstem cell-containing bone marrow is collected, stored, and

    infused following high-dose chemotherapy and/orradiation therapy.

    Peripheral blood stem cell (PBSC) transplantProcedure in which blood containing mobilized stem cells is

    collected by apheresis, stored, and infused following high-dose chemotherapy and/or radiation therapy.

    Cord blood transplants refer to transplants where thestem cells are obtained from umbilical cord bld

    Types of Transplants

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    100/106

    Autologous transplants, patients receive theirown stem cells.

    Syngeneic transplants, patients receive stem

    cells from their identical twin. Allogeneic transplants, patients receive stemcells from their brother, sister, orparent. A person who is not related to the

    patient (an unrelated donor) also may be used.

    yp paccording to Donor

    THE CANCER PAIN

    http://www.cancer.gov/dictionary/db_alpha.aspx?expand=ahttp://www.cancer.gov/dictionary/db_alpha.aspx?expand=ahttp://www.cancer.gov/dictionary/db_alpha.aspx?expand=ahttp://www.cancer.gov/dictionary/db_alpha.aspx?expand=a
  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    101/106

    PROBLEM

    PAINIn cancer is the most fearedand distressing symptom

    of the disease.

    THE CANCER PAINPROBLEM

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    102/106

    WHO reveals that everyday at least 4million people suffer from cancer pain.

    30 50% of cancer patients undergoingtreatment, and up to 95% of patients withadvanced disease, suffer from pain.

    More than 50% of patients still sufferedfrom unrelieved cancer pain.

    PROBLEM

    WHO: 3 Step Analgesic Ladder For

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    103/106

    Cancer Pain Management

    Basic Principles:

    BY THE MOUTH

    If the patient can swallow, oraladministration is the route of choice.

    WHO: 3 Step Analgesic Ladder ForC P i M

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    104/106

    BY THE CLOCK

    Analgesics should be given regularly and

    prophylactically.

    BY THE LADDER

    Use a few drugs well than many badly.

    Cancer Pain Management

    WHO Three-Step

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    105/106

    Analgesic Ladder Step I For mild to moderate pain non-opioids

    (treatment of choice). may or may not be combinedwith adjuvant drugs (drugs that are used to hasten oradd to the primary mode of treatment).

    Step II For moderate pain, who did not feel reliefafter using only non-opioids, a combination of opioidsand non-opioids should be tried. Again, adjuvants mayor may not be used.

    Step III For moderate to severe pain, opioids shouldbe used, with or without non-opioids, and with orwithout adjuvants.

    ancer :

  • 8/14/2019 Oncologic Nursing Part 2 Blaq

    106/106

    ManagementC Comfort

    A- Altered Body Image

    N Nutrition

    C Chemotherapy

    E- Evaluate the Response inTreatment

    R - Rest